1. Home
  2. BEEP vs ANIX Comparison

BEEP vs ANIX Comparison

Compare BEEP & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile Infrastructure Corporation

BEEP

Mobile Infrastructure Corporation

N/A

Current Price

$2.58

Market Cap

106.1M

Sector

Finance

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.98

Market Cap

103.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEP
ANIX
Founded
2015
1982
Country
United States
United States
Employees
N/A
4
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.1M
103.9M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
BEEP
ANIX
Price
$2.58
$2.98
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$5.83
★ $9.75
AVG Volume (30 Days)
24.3K
★ 218.1K
Earning Date
11-10-2026
09-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 12.82
EPS
N/A
★ N/A
Revenue
★ $35,075,000.00
$210,000.00
Revenue This Year
$1.47
N/A
Revenue Next Year
$11.40
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.29
$2.32
52 Week High
$3.78
$5.46

Technical Indicators

Market Signals
Indicator
BEEP
ANIX
Relative Strength Index (RSI) 41.88 57.76
Support Level $2.54 $2.82
Resistance Level $3.07 $3.09
Average True Range (ATR) 0.12 0.15
MACD -0.02 0.02
Stochastic Oscillator 45.38 75.93

Price Performance

Historical Comparison
BEEP
ANIX

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focus on acquiring, owning and optimizing parking facilities and related infrastructure, including parking lots, parking garages, and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provides access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: